Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Shiu-Fen Huang"'
Autor:
Wan-Ju Chen, Ming-Chin Yu, Shiu-Fen Huang, Kuo-Yang Lin, Sen-Yung Hsieh, Chih-Yun Hsu, Chee-Jen Chang, Yu-Jr Lin, Jung-Ru He, Tsung-Chieh Shih, Rabindranath Bera, Wen-Hui Weng
Publikováno v:
Hepatology. 53:504-516
Intrahepatic metastasis is the primary cause of the high recurrence and poor prognosis of human hepatocellular carcinoma (HCC). However, neither its molecular mechanisms nor markers for its prediction before hepatectomy have been identified. We recen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bb3956cee3f8b4fd30eee1b2a679b96
https://doi.org/10.1002/hep.24083
https://doi.org/10.1002/hep.24083
Autor:
Chiou-Shiang Wang, Chin-Pao Cheng, I-Ching Wang, Lee-Ming Chuang, Hui-Chuen Chen, Shiu-Fen Huang, Hui-Yu Peng
Publikováno v:
Diabetes Research and Clinical Practice. 120:S177-S178
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e80f996a674539088bc6f85f057df4c4
https://doi.org/10.1016/s0168-8227(16)31394-8
https://doi.org/10.1016/s0168-8227(16)31394-8
Autor:
Yow-Fu Tsai, Shiu-Fen Huang, Benjamin Yat-Ming Yung, Kuo-Yang Lin, Tse-Chin Chen, Tong-Hong Wang, Shao-Jung Lo, Li-Ching Fan, Yu-Jr Lin, Sen-Yung Hsieh, Hsiao-Ling Huang, Hsuan Liu, Chee-Jen Chang
Publikováno v:
Hepatology (Baltimore, Md.). 57(5)
Death evasion is crucial for both carcinogenesis and resistance to anticancer therapies. Recently, we identified nucleophosmin (NPM) as a key factor counteracting death stimuli in human hepatocellular carcinoma (HCC) cells. Here we report the identif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49ad1b0f6b426e12f8051d7f2f5bfb33
https://pubmed.ncbi.nlm.nih.gov/23258611
https://pubmed.ncbi.nlm.nih.gov/23258611
Autor:
Jen-Ruey Tang, Hung-Chieh Chou, Rong-Long Chen, Yen-Hsuan Ni, Shiu-Fen Huang, Kuo-Inn Tsou Yau
Publikováno v:
Medical and Pediatric Oncology. 38:203-204
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b1b7d195658aa41c97c17c58c51b4ff
https://doi.org/10.1002/mpo.1311
https://doi.org/10.1002/mpo.1311
Publikováno v:
Cancer Research. 70:3120-3120
Background & aims: Recent evidence that ERBB3 is responsible for tumor resistance to EGFR or ERBB2 targeted therapies highlighted its crucial role in the oncogenic signaling of EGFR family. However, its roles in hepatocelluar carcinoma (HCC) remain u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::13aec7de6745311de4a0264370e0d438
https://doi.org/10.1158/1538-7445.am10-3120
https://doi.org/10.1158/1538-7445.am10-3120